3.Association of face mask use with self-reported cardiovascular symptoms during the COVID-19 pandemic.
Nicholas Wen SHENG CHEW ; Raymond Ching CHIEW WONG ; Andie Hartanto DJOHAN ; Jinghao Nicholas NGIAM ; Ping CHAI ; Tiong-Cheng YEO ; Huay-Cheem TAN ; Ching-Hui SIA
Singapore medical journal 2023;64(10):609-615
INTRODUCTION:
Countries are mandating the use of face masks to stem the spread of coronavirus disease 2019 (COVID-19). Face mask use has been associated with discomfort due to its effects on thermoregulation, breathing and oxygenation. We evaluated the prevalence and severity of self-reported cardiovascular symptoms before and during face mask use.
METHODS:
This was a cross-sectional study of 1,001 participants residing in Singapore, who participated in a self-administered questionnaire between 25 April 2020 and 4 May 2020. Symptom severity before and during mask use, and health-seeking behaviour information were collected. The study outcome was self-reported worsening of cardiovascular symptoms and its association with the type of mask worn, duration of mask worn per day, and intensity of physical activities during mask use.
RESULTS:
The most common symptom reported during mask use was dyspnoea. Independent predictors for self-reported cardiovascular symptoms during mask use were moderate-high physical activity during mask use (odds ratio [OR] 1.634, 95% confidence interval [CI] 1.176-2.270, P = 0.003), duration of mask use for ≥3 h (OR 1.672, 95% CI 1.189-2.352, P = 0.003) and type of mask used, after adjusting for age, sex, healthcare-based worker status and presence of comorbidities. N95 mask was associated with worse symptoms when compared to surgical mask. Participants with ≥3 worsening symptoms or worsening dyspnoea, palpitations, fatigue and dizziness were more likely to seek medical help.
CONCLUSION
Face mask use has been proven to be an effective way in curbing COVID-19 transmission. However, participants in this study had concerns regarding its use and these concerns should be urgently addressed to enable mask use policies to be enacted.
Humans
;
COVID-19/epidemiology*
;
Pandemics
;
Masks/adverse effects*
;
Self Report
;
Cross-Sectional Studies
;
Dyspnea/etiology*
4.A review of COVID-19 vaccination and the reported cardiac manifestations.
Jamie Sin Ying HO ; Ching-Hui SIA ; Jinghao Nicholas NGIAM ; Poay Huan LOH ; Nicholas Wen Sheng CHEW ; William Kok-Fai KONG ; Kian-Keong POH
Singapore medical journal 2023;64(9):543-549
In Singapore, 9.03 million doses of the mRNA COVID-19 vaccines by Pfizer-BioNTech and Moderna have been administered, and 4.46 million people are fully vaccinated. An additional 87,000 people have been vaccinated with vaccines in World Health Organization's Emergency Use Listing. The aim of this review is to explore the reported cardiac adverse events associated with different types of COVID-19 vaccines. A total of 42 studies that reported cardiac side effects after COVID-19 vaccination were included in this study. Reported COVID-19 vaccine-associated cardiac adverse events were mainly myocarditis and pericarditis, most commonly seen in adolescent and young adult male individuals after mRNA vaccination. Reports of other events such as acute myocardial infarction, arrhythmia and stress cardiomyopathy were rare. Outcomes of post-vaccine myocarditis and pericarditis were good. Given the good vaccine efficacy and the high number of cases of infection, hospitalisation and death that could potentially be prevented, COVID-19 vaccine remains of overall benefit, based on the current available data.
Adolescent
;
Humans
;
Male
;
Young Adult
;
COVID-19/prevention & control*
;
COVID-19 Vaccines/adverse effects*
;
Myocarditis/etiology*
;
Pericarditis
;
RNA, Messenger
;
Vaccination/adverse effects*